Roche has revealed new results from a phase 2 trial of its oral BTK inhibitor fenebrutinib in relapsing multiple sclerosis (MS) that suggest it can prevent progression of the disease for nearly two ...
FORT MEADE, Fla. — In order to give the city more time to decide how to move forward, Fort Meade officials decided Tuesday to hold off on voting to approve plans for a new data center. The Fort Meade ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results